3033 GenAI In the Enterprise.pdf

1、October 21-24,2024Mandalay Bay Convention CenterLas Vegas,NevadaSession 3033Not Your Mamas GenAI Recipes OPEA and moreMelissa EversIntel Corporation,Vice President,Office of the CTONot Your Mamas GenAIRecipes OPEA and more#IBMTechXchangePerformance varies by use,configuration,and other factors.Learn

2、 more results are based on testing as of dates shown in configurations and may not reflect all publicly available updates.See backup for configuration details.No product or component can be absolutely secure.Your costs and results may vary.Intel technologies may require enabled hardware,software,or

3、service activation.Intel optimizations,for Intel compilers or other products,may not optimize to the same degree for non-Intel products.Intel does not control or audit third-party data.You should consult other sources to evaluate accuracy.Results have been estimated or simulated.Intel is committed t

4、o respecting human rights and avoiding complicity in human rights abuses.See IntelsGlobal Human Rights Principles.Intel products and software are intended only to be used in applications that do not cause or contribute to a violation of an internationally recognized human right.Intel Corporation.Int

5、el,the Intel logo,and other Intel marks are trademarks of Intel Corporation or its subsidiaries.*Other names and brands may be claimed as the property of others.Notices&Disclaimers#IBMTechXchangeAgendaEnvironment and ChallengesWhy OpenWhy RecipesOPEAOpenVINODeveloper ResourcesIBM TechXchange|2024 IB

6、M Corporation3#IBMTechXchangeChallenges bringing GenAIto ProductionIBM TechXchange|2024 IBM Corporation4StrategyGovernancePeopleApplicationsInfrastructureDataPlatformsPace of InnovationLicensing and Legal#IBMTechXchangeGenAI is emerging rapidlyemerging rapidly,but enterprises are struggling to reali